Main outcome measures
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of the Academy of Nutrition and Dietetics
- The prevalence, severity, and distribution of childhood food allergy in the United States.Pediatrics. 2011; 128: e9-e17
- The public health impact of parent-reported childhood food allergies in the United States.Pediatrics. 2018; 142e20181235
- Advancing food allergy through epidemiology: Understanding and addressing disparities in food allergy management and outcomes.J Allergy Clin Immunol Pract. 2021; 9: 110-118
- Racial differences in food allergy phenotype and health care utilization among US children.J Allergy Clin Immunol Pract. 2017; 5: 352-357.e1
- Food allergy management.Immunol Allergy Clin North Am. 2018; 38: 53-64
- Food allergen labeling and purchasing habits in the United States and Canada.J Allergy Clin Immunol Pract. 2017; 5: 345-351.e2
- Understanding precautionary allergen labeling (PAL) preferences among food allergy stakeholders.J Allergy Clin Immunol Pract. 2021; 9: 254-264
- Critical issues in food allergy: A national academies consensus report.Pediatrics. 2017; 140e20170194
- Food allergen knowledge, attitude and practices among UK consumers: A structural modelling approach.Food Res Int. 2019; 120: 375-381
- Food insecurity and caregiver perceptions of food allergen risk by food purchase location in children with food allergies.Transl Behav Med. 2019; 9: 404-412
- Correction to: Epidemiology and racial/ethnic differences in food allergy.in: Gupta R.S. Pediatric Food Allergy : A Clinical Guide. Springer International Publishing, 2020: C1
- Development of the Chicago Food Allergy Research Surveys: Assessing knowledge, attitudes, and beliefs of parents, physicians, and the general public.BMC Health Serv Res. 2009; 9 (142-142)
- Food allergy essentials: Common allergens. Accessed June 25, 2021.
- Stata Statistical Software. Version 15. StataCorp LLC, 2017
- Food allergy-related risk-taking and management behaviors among adolescents and young adults.J Allergy Clin Immunol Pract. 2017; 5: 381-390.e13
- Quality of life among food allergic patients and their caregivers.Curr Allergy Asthma Rep. 2016; 16: 38
- Pediatric food allergies and psychosocial functioning: Examining the potential moderating roles of maternal distress and overprotection.J Pediatr Psychol. 2015; 40: 1065-1074
- Urban/rural residence effect on emergency department visits arising from food-induced anaphylaxis.Allergol Int. 2019; 68: 316-320
- Parent perspectives on school food allergy policy.BMC Pediatr. 2018; 18: 164
- Voluntary guidelines for managing food allergies in schools and early care and education programs. US Department of Health and Human Services; 2013. Accessed July 10, 2021.
- Modifications to accommodate disabilities in the school meal programs. Accessed July 10, 2021.
STATEMENT OF POTENTIAL CONFLICT OF INTEREST R. S. Gupta is a medical consultant/advisor for Aimmune Therapeutics, Before Brands, AllerGenis LLC, Kaléo Inc, DBV Technologies, Pfizer, DOTS Technology, and Food Allergy Research and Education (FARE); has received grants from the National Institutes of Health (NIH) ( R21 ID # AI135705 , R01 ID# AI130348 , U01 ID # AI138907 ), Food Allergy Research Education (FARE), Rho Inc , Melchiorre Family Foundation , Sunshine Charitable Foundation , Walder Foundation , UnitedHealth Group , Thermo Fisher Scientific , Genentech , and the National Confectioners Association; is employed by Ann & Robert H. Lurie Children’s Hospital of Chicago; and is professor of pediatrics and medicine at Northwestern University Feinberg School of Medicine. L. A. Bilaver has received grants from NIH, Rho Inc, Thermo Fisher Scientific, FARE, Genentech, National Confectioners Association, and Before Brands. A. A. Pappalardo has worked with Boehringer-Ingelheim on their speaker’s bureau and in consultation in the past, starting in 2016 and ending August 2017. From August 2014 through July 2017, A. A. Pappalardo met with pharmaceutical representatives who provided lunch. A. A. Pappalardo serves a consultant for OptumRx/United Health Group. The remaining authors report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.
FUNDING/SUPPORT FORWARD (NIH number: R01AI130348). M. Mahdavinia is also supported by KL2TR002387-02 from NIH and Brinson Foundation grant.
AUTHOR CONTRIBUTIONS A. Robinson, J. Choi, J. Jiang, and H. Hultquist collected the data. J. L. Fierstein performed the data analysis. E. Vincent, L. A. Bilaver, and J. L. Fierstein wrote the first draft with contributions from A. A. Pappalardo, A. Coleman, H. P. Sharma, and A. Brewer. All authors reviewed and commented on subsequent drafts of the manuscript.